Journal
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Volume 34, Issue 4, Pages 833-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.rdc.2008.08.004
Keywords
Sjogren's syndrome; Etiology; Pathogenesis; IFN-alpha; B cells; Biomarkers
Categories
Funding
- European Union [BMH4-CT96-0595, BMH4-CT98-3489, QLK2-1999-51079, QLK2-CT-2001-30115, MEST-CT-2004-514483, MEIF-CT-2007-041083]
- Norwegian Research Council
- Strategic Research Program at Helse Bergen
- Western Norway Regional Health Authority
- Norwegian Cancer Society
- Broegelmann Foundation
Ask authors/readers for more resources
Sjogren's syndrome (SS) is a rheumatic disease in which the salivary and lacrimal glands are the principal targets of a pathologic autoimmune reaction. SS is manifested by xerostemia and keratoconjunctivitis sicca and marked by persistent focal mononuclear cell infiltration within the salivary glands, often accompanied by glandular atrophy and fibrosis. A challenge is to clarify the roles of genetic backgrounds and environmental trigger. Advanced bioanalytic platforms have enabled identification of potential biomarkers with the intent to improve diagnosis, promote development of prognostic tools, and identify processes for therapeutic treatment. Such approaches allow a glimpse at the apparent complexity of SS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available